You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 19, 2024

ACETAMINOPHEN, ASPIRIN AND CAFFEINE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Acetaminophen, Aspirin And Caffeine patents expire, and what generic alternatives are available?

Acetaminophen, Aspirin And Caffeine is a drug marketed by Aurobindo Pharma Ltd, Granules, and Perrigo. and is included in three NDAs.

The generic ingredient in ACETAMINOPHEN, ASPIRIN AND CAFFEINE is acetaminophen; aspirin; caffeine. There are sixty-six drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the acetaminophen; aspirin; caffeine profile page.

Summary for ACETAMINOPHEN, ASPIRIN AND CAFFEINE
Drug patent expirations by year for ACETAMINOPHEN, ASPIRIN AND CAFFEINE
Recent Clinical Trials for ACETAMINOPHEN, ASPIRIN AND CAFFEINE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Ache Laboratorios Farmaceuticos S.A.Phase 3
BayerPhase 2
BioHealthonomics Inc.Phase 2

See all ACETAMINOPHEN, ASPIRIN AND CAFFEINE clinical trials

US Patents and Regulatory Information for ACETAMINOPHEN, ASPIRIN AND CAFFEINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma Ltd ACETAMINOPHEN, ASPIRIN AND CAFFEINE acetaminophen; aspirin; caffeine TABLET;ORAL 211695-001 Feb 2, 2022 OTC No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Granules ACETAMINOPHEN, ASPIRIN AND CAFFEINE acetaminophen; aspirin; caffeine TABLET;ORAL 214039-001 Feb 23, 2021 OTC No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Perrigo ACETAMINOPHEN, ASPIRIN AND CAFFEINE acetaminophen; aspirin; caffeine TABLET;ORAL 075794-001 Nov 26, 2001 OTC No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.